Using Hb as a diagnostic tool for anemia in such cases could result in overtreatment with erythropoietin, a drug known to be associated with increased mortality.[2] Indeed, in patients with heart failure, a blood-volume-guided treatment for anemia or diuresis is reportedly associated with better outcomes.[15,16]. This evidence concerns the gene GSTM1 and anemia (phenotype).